大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/01 | 4,564 | 4,643 | 4,531 | 4,620 | +126 | +2.8% | 1,180,000 |
2021/10/29 | 4,530 | 4,531 | 4,441 | 4,494 | -25 | -0.6% | 697,400 |
2021/10/28 | 4,580 | 4,599 | 4,519 | 4,519 | -127 | -2.7% | 821,700 |
2021/10/27 | 4,649 | 4,673 | 4,630 | 4,646 | -7 | -0.2% | 483,800 |
2021/10/26 | 4,636 | 4,692 | 4,618 | 4,653 | +60 | +1.3% | 628,000 |
2021/10/25 | 4,616 | 4,645 | 4,593 | 4,593 | -55 | -1.2% | 643,200 |
2021/10/22 | 4,618 | 4,686 | 4,618 | 4,648 | -4 | -0.1% | 664,500 |
2021/10/21 | 4,729 | 4,737 | 4,639 | 4,652 | -73 | -1.5% | 603,600 |
2021/10/20 | 4,720 | 4,762 | 4,697 | 4,725 | +7 | +0.1% | 608,200 |
2021/10/19 | 4,771 | 4,817 | 4,718 | 4,718 | -82 | -1.7% | 566,500 |
2021/10/18 | 4,847 | 4,849 | 4,784 | 4,800 | -50 | -1% | 607,500 |
2021/10/15 | 4,837 | 4,867 | 4,821 | 4,850 | +28 | +0.6% | 722,000 |
2021/10/14 | 4,780 | 4,835 | 4,743 | 4,822 | +40 | +0.8% | 720,000 |
2021/10/13 | 4,759 | 4,817 | 4,753 | 4,782 | -4 | -0.1% | 468,300 |
2021/10/12 | 4,821 | 4,843 | 4,772 | 4,786 | -54 | -1.1% | 586,400 |
2021/10/11 | 4,776 | 4,865 | 4,758 | 4,840 | +5 | +0.1% | 840,500 |
2021/10/08 | 4,858 | 4,911 | 4,820 | 4,835 | +71 | +1.5% | 936,500 |
2021/10/07 | 4,745 | 4,786 | 4,691 | 4,764 | +9 | +0.2% | 736,100 |
2021/10/06 | 4,764 | 4,799 | 4,701 | 4,755 | +8 | +0.2% | 654,100 |
2021/10/05 | 4,798 | 4,817 | 4,710 | 4,747 | -95 | -2% | 744,700 |
2021/10/04 | 4,826 | 4,863 | 4,811 | 4,842 | +61 | +1.3% | 795,900 |
2021/10/01 | 4,811 | 4,858 | 4,759 | 4,781 | -6 | -0.1% | 972,200 |
2021/09/30 | 4,837 | 4,856 | 4,772 | 4,787 | -25 | -0.5% | 1,335,100 |
2021/09/29 | 4,776 | 4,815 | 4,752 | 4,812 | +1 | ±0% | 1,022,000 |
2021/09/28 | 4,823 | 4,834 | 4,758 | 4,811 | -67 | -1.4% | 1,242,000 |
2021/09/27 | 4,939 | 4,955 | 4,866 | 4,878 | -70 | -1.4% | 828,500 |
2021/09/24 | 4,900 | 4,959 | 4,896 | 4,948 | +122 | +2.5% | 1,187,700 |
2021/09/22 | 4,867 | 4,882 | 4,812 | 4,826 | -31 | -0.6% | 699,300 |
2021/09/21 | 4,890 | 4,896 | 4,843 | 4,857 | -34 | -0.7% | 956,000 |
2021/09/17 | 4,929 | 4,943 | 4,886 | 4,891 | -40 | -0.8% | 1,578,200 |
2021/09/16 | 4,889 | 4,934 | 4,868 | 4,931 | +64 | +1.3% | 660,700 |
2021/09/15 | 4,882 | 4,893 | 4,857 | 4,867 | -43 | -0.9% | 723,400 |
2021/09/14 | 4,909 | 4,924 | 4,868 | 4,910 | -33 | -0.7% | 1,055,200 |
2021/09/13 | 4,933 | 4,950 | 4,870 | 4,943 | -10 | -0.2% | 738,900 |
2021/09/10 | 4,972 | 4,981 | 4,889 | 4,953 | -36 | -0.7% | 1,469,000 |
2021/09/09 | 4,973 | 5,013 | 4,968 | 4,989 | ±0 | ±0% | 901,100 |
2021/09/08 | 4,979 | 5,005 | 4,950 | 4,989 | +19 | +0.4% | 1,244,000 |
2021/09/07 | 4,958 | 4,991 | 4,921 | 4,970 | +78 | +1.6% | 918,100 |
2021/09/06 | 4,925 | 4,948 | 4,889 | 4,892 | -26 | -0.5% | 715,700 |
2021/09/03 | 4,806 | 4,923 | 4,777 | 4,918 | +157 | +3.3% | 1,088,000 |
2021/09/02 | 4,756 | 4,807 | 4,723 | 4,761 | +6 | +0.1% | 776,400 |
2021/09/01 | 4,692 | 4,765 | 4,682 | 4,755 | +74 | +1.6% | 743,000 |
2021/08/31 | 4,594 | 4,708 | 4,575 | 4,681 | +32 | +0.7% | 1,218,000 |
2021/08/30 | 4,627 | 4,649 | 4,584 | 4,649 | +17 | +0.4% | 919,900 |
2021/08/27 | 4,692 | 4,719 | 4,627 | 4,632 | -64 | -1.4% | 668,900 |
2021/08/26 | 4,672 | 4,712 | 4,654 | 4,696 | +24 | +0.5% | 742,800 |
2021/08/25 | 4,726 | 4,726 | 4,669 | 4,672 | -70 | -1.5% | 614,700 |
2021/08/24 | 4,729 | 4,763 | 4,712 | 4,742 | -28 | -0.6% | 744,600 |
2021/08/23 | 4,743 | 4,804 | 4,743 | 4,770 | +44 | +0.9% | 722,800 |
2021/08/20 | 4,732 | 4,785 | 4,709 | 4,726 | +10 | +0.2% | 791,800 |
751~
800
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム